✦ LIBER ✦

Sudomotor testing predicts the presence of neutralizing botulinum A toxin antibodies

✍ Scribed by Frank Birklein; Dirk Walther; Hans Bigalke; Martin Winterholler; Frank Erbguth

Publisher: John Wiley and Sons
Year: 2002
Tongue: English
Weight: 81 KB
Volume: 52
Category: Article
ISSN: 0364-5134
DOI: 10.1002/ana.10243

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sudomotor testing discriminates between

Sudomotor testing discriminates between subjects with and without antibodies against botulinum toxin A—A preliminary observation

✍ Frank Birklein; Frank Erbguth 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 209 KB

With an increasing number of patients being treated with botulinum toxin A (BTX A), the incidence of neutralizing anti-BTX antibodies (ABA) is rising. Because BTX A is known to inhibit sweating, sudometry seems to be a promising tool to test the efficacy of BTX A. We injected BTX A subcutaneously in

Ninhydrin sweat test: A simple method fo

Ninhydrin sweat test: A simple method for detecting antibodies neutralizing botulinum toxin type A

✍ Bernhard Voller; Ekaterina Moraru; Eduard Auff; Michael Benesch; Werner Poewe; J 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

## Abstract Approximately 5% of patients with cervical dystonia receiving repeated botulinum neurotoxin A (BoNT/A) injections develop secondary loss of treatment benefit. Currently available tests to directly detect neutralizing BoNT/A antibodies (BoNT/A‐AB) are either expensive or time consuming.

Mycophenolate in the prevention of recur

Mycophenolate in the prevention of recurrent neutralizing botulinum toxin A antibodies in cervical dystonia

✍ Drake D. Duane; John Monroe; Randall E. Morris 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 51 KB

The EDB Test—A clinical test for the det

The EDB Test—A clinical test for the detection of antibodies to botulinum toxin type A

✍ Kirn R. Kessler; Dr. Reiner Benecke 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB

## Abstract Approximately 5 to 10% of patients with cervical, segmental or multifocal dystonia receiving repetitive local injections with botulinum toxin A (BTX A) are estimated to develop secondary loss of treatment benefit (nonresponding) because of the formation of circulating serum antibodies a

Secondary nonresponsiveness to botulinum

Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: The role of electromyogram-guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test

✍ Carla Cordivari; Vijay Peter Misra; Angela Vincent; Santiago Catania; Kailash P. 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB

## Abstract We studied 20 patients with cervical dystonia who had started to respond poorly to botulinum toxin A (BTXA) injections after an initial good response. All patients had extensor digitorum brevis (EDB) tests performed in addition to BTXA immunoprecipition assay (IPA) and mouse bioassay (M

Enterovirus heart disease of adults: A p

Enterovirus heart disease of adults: A persistent, limited organ infection in the presence of neutralizing antibodies

✍ Heim, Albert; Grumbach, Isabella; Hake, Sabine; Müller, Gudrun; Pring-Åkerblom, 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB 👁 1 views

Detection of enterovirus RNA in endomyocardial biopsies (EMB) by reverse transcription/polymerase chain reaction (RT-PCR) is currently the preferred diagnostic procedure in suspected enterovirus heart disease (EHD), which can present clinically as myocarditis, dilated cardiomyopathy (DCM), and arrhy